あすか製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証1部 | 医薬品 | 4514/E00929 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/09/06 | 日証協 | 361,539株 | -3.61% | 55,671株 | +6.26% | 242,224株 | 0% | 8,100株 | -61.07% |
2019/08/30 | 日証協 | 375,071株 | -1.11% | 52,391株 | -22.54% | 242,220株 | -1.58% | 20,804株 | -22.95% |
2019/08/23 | 日証協 | 379,271株 | -11.22% | 67,638株 | -47.66% | 246,120株 | -11.64% | 27,000株 | -30.75% |
2019/08/16 | 日証協 | 427,182株 | +13.24% | 129,222株 | +99.22% | 278,558株 | +8.32% | 38,988株 | -51.66% |
2019/08/09 | 日証協 | 377,227株 | -5.42% | 64,864株 | -32.53% | 257,157株 | +32.62% | 80,658株 | +1052.26% |
2019/08/02 | 日証協 | 398,827株 | +0.12% | 96,136株 | -21.16% | 193,904株 | +1.68% | 7,000株 | -48.86% |
2019/07/26 | 日証協 | 398,356株 | -0.74% | 121,943株 | +23.52% | 190,704株 | +0.79% | 13,689株 | +5.39% |
2019/07/19 | 日証協 | 401,345株 | -0.4% | 98,724株 | -19.37% | 189,204株 | -1.36% | 12,989株 | -74.43% |
2019/07/12 | 日証協 | 402,945株 | +0.13% | 122,440株 | -38.42% | 191,804株 | -6.89% | 50,789株 | -50.3% |
2019/07/05 | 日証協 | 402,427株 | -4.73% | 198,843株 | +37.67% | 206,004株 | -10.13% | 102,200株 | +54.15% |
2019/06/28 | 日証協 | 422,416株 | +43.54% | 144,439株 | +142.55% | 229,217株 | +4.83% | 66,300株 | +426.19% |
2019/06/21 | 日証協 | 294,283株 | +2.91% | 59,550株 | +220.16% | 218,665株 | -0.36% | 12,600株 | -58.06% |
2019/06/14 | 日証協 | 285,971株 | -0.66% | 18,600株 | -75% | 219,465株 | -13.52% | 30,040株 | +68.76% |
2019/06/07 | 日証協 | 287,871株 | -1.92% | 74,411株 | -45.34% | 253,765株 | -22.32% | 17,800株 | -84.12% |
2019/05/31 | 日証協 | 293,501株 | -14.23% | 136,135株 | +14.19% | 326,665株 | -9.23% | 112,097株 | +242.8% |
2019/05/24 | 日証協 | 342,180株 | +6.22% | 119,214株 | -34.67% | 359,865株 | -1.53% | 32,700株 | -54.54% |
2019/05/17 | 日証協 | 322,128株 | -1.53% | 182,470株 | +108.7% | 365,460株 | -4.21% | 71,926株 | +1338.52% |
2019/05/10 | 日証協 | 327,128株 | -4.52% | 87,432株 | +7.67% | 381,539株 | -5.31% | 5,000株 | -45.65% |
2019/04/26 | 日証協 | 342,622株 | -24.23% | 81,200株 | -26.18% | 402,939株 | -22.74% | 9,200株 | -48.63% |
※株式分割は考慮していませんのでご注意ください。
Page Top